↓ Skip to main content

Cochrane Database of Systematic Reviews

Intra‐pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema

Overview of attention for article published in Cochrane database of systematic reviews, October 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

blogs
1 blog
twitter
11 X users
facebook
1 Facebook page

Citations

dimensions_citation
68 Dimensions

Readers on

mendeley
190 Mendeley
Title
Intra‐pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema
Published in
Cochrane database of systematic reviews, October 2019
DOI 10.1002/14651858.cd002312.pub4
Pubmed ID
Authors

Emile S Altmann, Iain Crossingham, Stephen Wilson, Huw R Davies

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 190 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 190 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 25 13%
Student > Master 19 10%
Researcher 15 8%
Other 11 6%
Student > Doctoral Student 11 6%
Other 27 14%
Unknown 82 43%
Readers by discipline Count As %
Medicine and Dentistry 59 31%
Pharmacology, Toxicology and Pharmaceutical Science 8 4%
Nursing and Health Professions 7 4%
Psychology 4 2%
Immunology and Microbiology 3 2%
Other 19 10%
Unknown 90 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2024.
All research outputs
#2,505,251
of 25,890,819 outputs
Outputs from Cochrane database of systematic reviews
#4,975
of 13,156 outputs
Outputs of similar age
#51,719
of 379,451 outputs
Outputs of similar age from Cochrane database of systematic reviews
#90
of 204 outputs
Altmetric has tracked 25,890,819 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.2. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 379,451 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 204 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.